Chardan Capital Markets正式启动对ProMIS Neurosciences Inc的覆盖研究，给予该股“买入”评级，并设定20美元的目标价。这一举措，无疑为这家专注于神经科学领域的公司注入了新的市场关注度。
Chardan Capital Markets正式启动对ProMIS Neurosciences Inc的覆盖研究，给予该股“买入”评级，并设定20美元的目标价。这一举措，无疑为这家专注于神经科学领域的公司注入了新的市场关注度。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.